These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27846946)

  • 81. Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis.
    Gisondi P; Girolomoni G
    Drug Des Devel Ther; 2016; 10():1763-70. PubMed ID: 27307707
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA × BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data.
    Gottlieb AB; Merola JF; Chen R; Levi E; Duffin KC
    J Am Acad Dermatol; 2017 Dec; 77(6):1178-1180. PubMed ID: 29132853
    [No Abstract]   [Full Text] [Related]  

  • 83. Appearance of lentigines in psoriasis patient treated with guselkumab.
    Lee EB; Reynolds KA; Pithadia DJ; Wu JJ
    Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710906
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The pharmacodynamic impact of apremilast, an oral phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1).
    Schafer PH; Chen P; Fang L; Wang A; Chopra R
    J Immunol Res; 2015; 2015():906349. PubMed ID: 25973439
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Improvement of alopecia areata with apremilast.
    Magdaleno-Tapial J; Valenzuela-Oñate C; Sánchez-Carazo JL; Alegre-de Miquel V
    Australas J Dermatol; 2019 May; 60(2):144-145. PubMed ID: 30294781
    [No Abstract]   [Full Text] [Related]  

  • 86. Comparative morphometric study of eruptive PUVA-induced and chronic sun-induced lentigines of the skin.
    Nikkels A; Ben Mosbah T; Piérard-Franchimont C; de la Brassinne M; Piérard GE
    Anal Quant Cytol Histol; 1991 Feb; 13(1):23-6. PubMed ID: 2025370
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast.
    Krase IZ; Cavanaugh K; Curiel-Lewandrowski C
    JAMA Dermatol; 2016 Mar; 152(3):348-50. PubMed ID: 26536384
    [No Abstract]   [Full Text] [Related]  

  • 88. Apremilast in treatment of palmoplantar pustulosis - a case series.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Int J Dermatol; 2021 Jun; 60(6):e247-e248. PubMed ID: 33475149
    [No Abstract]   [Full Text] [Related]  

  • 89. Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Nittala R; Singh A
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3057. PubMed ID: 32109638
    [No Abstract]   [Full Text] [Related]  

  • 90. Case of psoriasis vulgaris with atrial fibrillation, heart failure and chronic kidney disease which were found accidentally through blood examination during apremilast treatment.
    Tokuyama M; Shimizu T; Yamada T; Kondoh A; Mabuchi T
    J Dermatol; 2019 Jul; 46(7):e239-e240. PubMed ID: 30663127
    [No Abstract]   [Full Text] [Related]  

  • 91. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.
    Baughman RP; Judson MA; Ingledue R; Craft NL; Lower EE
    Arch Dermatol; 2012 Feb; 148(2):262-4. PubMed ID: 22004880
    [No Abstract]   [Full Text] [Related]  

  • 92. Apremilast for the off-label treatment of lichenoid and interface dermatoses.
    Ravichandran S; Kheterpal MK
    J Am Acad Dermatol; 2020 Nov; 83(5):1489-1491. PubMed ID: 32497705
    [No Abstract]   [Full Text] [Related]  

  • 93. Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis.
    Haller C; Cozzio A; von Kempis J; Rubbert-Roth A
    J Clin Rheumatol; 2021 Oct; 27(7):e289-e290. PubMed ID: 32453211
    [No Abstract]   [Full Text] [Related]  

  • 94. New Therapies for Psoriasis.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S71-3. PubMed ID: 27525355
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy.
    Gutiérrez-González E; Batalla A; de la Mano D
    Dermatol Online J; 2014 Apr; 20(4):22338. PubMed ID: 24746301
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
    Genovese MC; Jarosova K; Cieślak D; Alper J; Kivitz A; Hough DR; Maes P; Pineda L; Chen M; Zaidi F
    Arthritis Rheumatol; 2015 Jul; 67(7):1703-10. PubMed ID: 25779750
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Lentigines in resolving psoriatic plaques: rarely reported sequelae in pediatric cases.
    LaRosa CL; Foulke GT; Feigenbaum DF; Cordoro KM; Zaenglein AL
    Pediatr Dermatol; 2015; 32(3):e114-7. PubMed ID: 25727728
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Thalidomide in the treatment of psoriasis vulgaris: a pilot study.
    Li L; Su F; Jin H
    J Dermatol; 2011 Dec; 38(12):1180-2. PubMed ID: 22035041
    [No Abstract]   [Full Text] [Related]  

  • 99. Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor.
    Man HW; Schafer P; Wong LM; Patterson RT; Corral LG; Raymon H; Blease K; Leisten J; Shirley MA; Tang Y; Babusis DM; Chen R; Stirling D; Muller GW
    J Med Chem; 2009 Mar; 52(6):1522-4. PubMed ID: 19256507
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lentigines in previous psoriatic plaques in a patient treated with infliximab.
    Bardazzi F; Magnano M; Antonucci VA; Balestri R; Sgubbi P; Patrizi A
    Eur J Dermatol; 2012; 22(5):698-9. PubMed ID: 22940696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.